10/14/2026
Tofacitinib and upadacitinib are key treatment options for advanced management of inflammatory bowel disease (IBD). As medication experts, pharmacists play a critical role in identifying risks, monitoring therapy, and helping ensure the safe and effective use of these JAK inhibitors. Looking to build your confidence in this area? Enrol in the complimentary, CCCEP-accredited, online course Practical Pharmacist Strategies for Managing IBD with JAK Inhibitors. Pharmacists have described the course modules as “short and to the point,” and “relevant to daily practice” and valued the counselling points video featuring a pharmacist with practice experience in immunology. Enhance your knowledge and effectively support patients living with IBD.
Enrol now: https://qrco.de/bgxKww